FDA approves four new Cochlear products

FDA approves four new Cochlear products

The US Food and Drug Administration (FDA) has approved four new products from hearing implant technology company Cochlear (ASX: COH), enabling smartphone connectivity for users, while clinicians and surgeons will benefit from new software and tools. 

The Sydney-headquartered company plans to commercially release the new products in the US and Western Europe in the next few months, subject to local approvals.

COH shares have risen 2.2 per cent to $196.95 each in early trading following the announcement.

One of the products to be approved is the Nucleus Kanso 2 Sound Processor, which is the world's smallest off-the-ear cochlear implant sound processor and the first of its kind to offer direct streaming from compatible Apple or Android devices.

"The Nucleus Kanso 2 Sound Processor showcases Cochlear's latest and most advanced hearing performance technology," says Cochlear CEO and president Dig Howitt.

"With our latest connectivity features and a simple design that is comfortable and discreet, it really is designed to help cochlear implant recipients enrich their lives."

The Cochlear Nucleus 7 Sound Processor will also be released for people with the Nucleus 22 implant, allowing them to also access direct smartphone connectivity and streaming for the first time.

"The Nucleus 22 implant was Cochlear's first commercial implant, released in 1982. There are more than 17,000 people around the world with a Nucleus 22 implant," says Howitt.

"This upgrade means that for the first time people who have benefitted from their implant for almost 40 years can access direct smartphone connectivity as well as a smaller and lighter design."

FDA approval has been given to Cochlear's Custom Sound fitting software for clinicians, including a new more intuitive dashboard and Patient Goals feature, while the company's Nucleus SmartNav system has also been given the green light to help surgeons in optimise electrode placement during cochlear implant surgery.

"To help patients experience the best possible hearing performance, it's important that programming software for cochlear implant sound processors provide flexibility and be easy to use," the group says.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Get our daily business news

Sign up to our free email news updates.

 
Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

‘Heat of the moment’: The Star’s chair regrets inflammatory texts with CEO

‘Heat of the moment’: The Star’s chair regrets inflammatory texts with CEO

The Star Entertainment Group’s (ASX: SGR) executive chairman ...

Lifestyle Communities sheds $254m as shares plunge on home settlements downgrade

Lifestyle Communities sheds $254m as shares plunge on home settlements downgrade

Shares in Lifestyle Communities (ASX: LIC) have reached their lowes...

Vastly bigger than the Black Summer: 84 million hectares of northern Australia burned in 2023

Vastly bigger than the Black Summer: 84 million hectares of northern Australia burned in 2023

It may come as a surprise to hear 2023 was Australia’s bigges...

Crown retains NSW casino licence after regaining trust of regulator

Crown retains NSW casino licence after regaining trust of regulator

Crown Resorts has regained the trust of the NSW regulator which tod...